Similar Items: A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
- A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
- Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
- Lopinavir/ Ritonavir, an Antiretroviral Drug, Lowers Sperm Quality and Induces Testicular Oxidative Damage in Rats
- Comparison of Four Covariate Adjustment Methods in Analysis of Mathematics Achievement in Randomised Controlled Trials among Senior Secondary School Students
- Investigating the multifaceted host contribution to COVID-19 disease risk, progression and treatment: an integrative multi-omics network-based approach study
- Bayesian approach to survival modeling of remission duration for acute leukemia